NR2E3 and Ewing sarcoma: In summary, these data suggest that induction of apoptosis in Ewing sarcoma cells by RNR inhibitors require an extended treatment duration and that the reversibility of clofarabine, in combination with its in vivo half-life of ~5-7 hours, may limit the effectiveness of this drug in a clinical setting.